BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 18568894)

  • 1. Acute actinic cheilitis-like chemical irritant reaction following accidental contact with ethylene glycol-favorable response to topical 1% pimecrolimus cream: a case report.
    Erkek E; Kazkayasi M; Bozdogan O
    Cutan Ocul Toxicol; 2008; 27(2):91-5. PubMed ID: 18568894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of cheilitis glandularis superimposed on oral lichen planus: successful palliative treatment with topical tacrolimus and pimecrolimus.
    Erkek E; Sahin S; Kilic R; Erdogan S
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):999-1000. PubMed ID: 17659026
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful treatment of plasma cell cheilitis with topical tacrolimus: report of two cases.
    Hanami Y; Motoki Y; Yamamoto T
    Dermatol Online J; 2011 Feb; 17(2):6. PubMed ID: 21382289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma cell cheilitis, successfully treated with topical 0.03% tacrolimus ointment.
    Jin SP; Cho KH; Huh CH
    J Dermatolog Treat; 2010 May; 21(3):130-2. PubMed ID: 19707925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with pimecrolimus cream 1% clears irritant dermatitis of the periocular region, face and neck.
    Mensing CO; Mensing CH; Mensing H
    Int J Dermatol; 2008 Sep; 47(9):960-4. PubMed ID: 18937664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical pimecrolimus and tacrolimus transiently induce neuropeptide release and mast cell degranulation in murine skin.
    Ständer S; Ständer H; Seeliger S; Luger TA; Steinhoff M
    Br J Dermatol; 2007 May; 156(5):1020-6. PubMed ID: 17388925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exfoliative cheilitis successfully treated with topical tacrolimus.
    Connolly M; Kennedy C
    Br J Dermatol; 2004 Jul; 151(1):241-2. PubMed ID: 15270904
    [No Abstract]   [Full Text] [Related]  

  • 8. Hemophagocytic syndrome and acute liver failure associated with ethylene glycol ingestion: a case report.
    Kuskonmaz B; Duzova A; Kanbur NO; Gurakan F; Gumruk F; Gurgey A
    Pediatr Hematol Oncol; 2006; 23(5):427-32. PubMed ID: 16728363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facial actinic lichen planus following the Blaschko's lines: successful treatment with topical 0.1% pimecrolimus cream.
    Ezzedine K; Simonart T; Vereecken P; Heenen M
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):458-9. PubMed ID: 18624870
    [No Abstract]   [Full Text] [Related]  

  • 10. Two therapeutic challenges: periocular and genital vitiligo in children successfully treated with pimecrolimus cream.
    Souza Leite RM; Craveiro Leite AA
    Int J Dermatol; 2007 Sep; 46(9):986-9. PubMed ID: 17822508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annular elastolytic giant cell granuloma in an infant: improvement after treatment with oral tranilast and topical pimecrolimus.
    Lee HW; Lee MW; Choi JH; Moon KC; Koh JK
    J Am Acad Dermatol; 2005 Nov; 53(5 Suppl 1):S244-6. PubMed ID: 16227100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of pimecrolimus and tacrolimus to skin and plasma proteins: implications for systemic exposure after topical application.
    Weiss HM; Fresneau M; Moenius T; Stuetz A; Billich A
    Drug Metab Dispos; 2008 Sep; 36(9):1812-8. PubMed ID: 18524871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on the safety and tolerability of pimecrolimus cream 1%: evidence from clinical trials and post-marketing surveillance.
    Langley RG; Luger TA; Cork MJ; Schneider D; Paul C
    Dermatology; 2007; 215 Suppl 1():27-44. PubMed ID: 18174691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A topical imiquimod-induced oral mucosal lichenoid reaction: a case report.
    Brown RS; Farquharson AA
    J Am Dent Assoc; 2014 Nov; 145(11):1141-5. PubMed ID: 25359646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated lip dermatitis (atopic cheilitis), successfully treated with topical tacrolimus 0.03.
    Georgakopoulou E; Loumou P; Grigoraki A; Panagiotopoulos A
    Med Oral Patol Oral Cir Bucal; 2021 May; 26(3):e357-e360. PubMed ID: 33340078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of topical calcineurin inhibitors in lupus erythematosus: an overview.
    Wollina U; Hansel G
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):1-6. PubMed ID: 18005117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of chronic actinic dermatitis with topical pimecrolimus.
    Larangeira de Almeida H
    Int J Dermatol; 2005 Apr; 44(4):343-4. PubMed ID: 15811093
    [No Abstract]   [Full Text] [Related]  

  • 18. Two cases of Zoon's balanitis treated with pimecrolimus 1% cream.
    Bardazzi F; Antonucci A; Savoia F; Balestri R
    Int J Dermatol; 2008 Feb; 47(2):198-201. PubMed ID: 18211499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical pimecrolimus and tacrolimus do not accelerate photocarcinogenesis in hairless mice after UVA or simulated solar radiation.
    Lerche CM; Philipsen PA; Poulsen T; Wulf HC
    Exp Dermatol; 2009 Mar; 18(3):246-51. PubMed ID: 19183401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer risk with topical pimecrolimus and tacrolimus.
    Prescrire Int; 2005 Dec; 14(80):223. PubMed ID: 16400745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.